Logo image of AL2SI.PA

2CRSI SA (AL2SI.PA) Stock Fundamental Analysis

EPA:AL2SI - Euronext Paris - Matif - FR0013341781 - Common Stock - Currency: EUR

4.355  -0.06 (-1.36%)

Fundamental Rating

3

AL2SI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 28 industry peers in the Technology Hardware, Storage & Peripherals industry. The financial health of AL2SI is average, but there are quite some concerns on its profitability. AL2SI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

AL2SI had negative earnings in the past year.
In the past year AL2SI has reported a negative cash flow from operations.
AL2SI had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AL2SI reported negative operating cash flow in multiple years.
AL2SI.PA Yearly Net Income VS EBIT VS OCF VS FCFAL2SI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

AL2SI's Return On Assets of -9.21% is on the low side compared to the rest of the industry. AL2SI is outperformed by 75.00% of its industry peers.
Looking at the Return On Equity, with a value of -25.51%, AL2SI is doing worse than 64.29% of the companies in the same industry.
Industry RankSector Rank
ROA -9.21%
ROE -25.51%
ROIC N/A
ROA(3y)-6%
ROA(5y)-4.94%
ROE(3y)-24.19%
ROE(5y)-19.4%
ROIC(3y)N/A
ROIC(5y)N/A
AL2SI.PA Yearly ROA, ROE, ROICAL2SI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

AL2SI has a better Gross Margin (95.25%) than 100.00% of its industry peers.
AL2SI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AL2SI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5YN/A
AL2SI.PA Yearly Profit, Operating, Gross MarginsAL2SI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

AL2SI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AL2SI has more shares outstanding
AL2SI has a better debt/assets ratio than last year.
AL2SI.PA Yearly Shares OutstandingAL2SI.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M
AL2SI.PA Yearly Total Debt VS Total AssetsAL2SI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

AL2SI has an Altman-Z score of 3.62. This indicates that AL2SI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AL2SI (3.62) is better than 78.57% of its industry peers.
AL2SI has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.25, AL2SI belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 3.62
ROIC/WACCN/A
WACC6.92%
AL2SI.PA Yearly LT Debt VS Equity VS FCFAL2SI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.45 indicates that AL2SI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.45, AL2SI is in line with its industry, outperforming 53.57% of the companies in the same industry.
AL2SI has a Quick Ratio of 1.45. This is a bad value and indicates that AL2SI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.91, AL2SI is not doing good in the industry: 60.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.91
AL2SI.PA Yearly Current Assets VS Current LiabilitesAL2SI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

AL2SI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.98%, which is quite impressive.
AL2SI shows a decrease in Revenue. In the last year, the revenue decreased by -2.51%.
Measured over the past years, AL2SI shows a small growth in Revenue. The Revenue has been growing by 3.08% on average per year.
EPS 1Y (TTM)64.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.56%
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y3.08%
Revenue growth 5YN/A
Sales Q2Q%90.71%

3.2 Future

The Earnings Per Share is expected to grow by 244.88% on average over the next years. This is a very strong growth
Based on estimates for the next years, AL2SI will show a quite strong growth in Revenue. The Revenue will grow by 19.84% on average per year.
EPS Next Y1822.23%
EPS Next 2Y503.69%
EPS Next 3Y244.88%
EPS Next 5YN/A
Revenue Next Year28.38%
Revenue Next 2Y25.93%
Revenue Next 3Y19.84%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AL2SI.PA Yearly Revenue VS EstimatesAL2SI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AL2SI.PA Yearly EPS VS EstimatesAL2SI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AL2SI. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 7.33, the valuation of AL2SI can be described as very cheap.
Based on the Price/Forward Earnings ratio, AL2SI is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, AL2SI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 7.33
AL2SI.PA Price Earnings VS Forward Price EarningsAL2SI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

AL2SI's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AL2SI is more expensive than 60.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 41.36
AL2SI.PA Per share dataAL2SI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

AL2SI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AL2SI's earnings are expected to grow with 244.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y503.69%
EPS Next 3Y244.88%

0

5. Dividend

5.1 Amount

AL2SI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

2CRSI SA

EPA:AL2SI (3/7/2025, 7:00:00 PM)

4.355

-0.06 (-1.36%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)N/A N/A
Earnings (Next)03-27 2025-03-27
Inst Owners9.37%
Inst Owner ChangeN/A
Ins Owners55.49%
Ins Owner ChangeN/A
Market Cap97.16M
Analysts87.27
Price Target8.5 (95.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP-56.17%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.41%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)51.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)14.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.33
P/S 0.54
P/FCF N/A
P/OCF N/A
P/B 3.68
P/tB 4.75
EV/EBITDA 41.36
EPS(TTM)-0.3
EYN/A
EPS(NY)0.59
Fwd EY13.64%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS8.02
BVpS1.18
TBVpS0.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.21%
ROE -25.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.25%
FCFM N/A
ROA(3y)-6%
ROA(5y)-4.94%
ROE(3y)-24.19%
ROE(5y)-19.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5YN/A
F-Score6
Asset Turnover2.44
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA 2.59
Cap/Depr 51.18%
Cap/Sales 1.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 0.91
Altman-Z 3.62
F-Score6
WACC6.92%
ROIC/WACCN/A
Cap/Depr(3y)93.52%
Cap/Depr(5y)80.3%
Cap/Sales(3y)1.3%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.56%
EPS Next Y1822.23%
EPS Next 2Y503.69%
EPS Next 3Y244.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y3.08%
Revenue growth 5YN/A
Sales Q2Q%90.71%
Revenue Next Year28.38%
Revenue Next 2Y25.93%
Revenue Next 3Y19.84%
Revenue Next 5YN/A
EBIT growth 1Y76.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year230.91%
EBIT Next 3Y108.56%
EBIT Next 5YN/A
FCF growth 1Y-158.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-126.1%
OCF growth 3YN/A
OCF growth 5YN/A